Molecular changes in heart failure -- Hemodynamics and heart failure -- Imaging and heart failure -- Acute and chronic right ventricular failure -- Inhibition of the renin-angiotensin-aldosterone system -- Inhibition of the sympathetic nervous system -- Management of the patient with heart failure with preserved ejection fraction -- Acute decompensated heart failure: classification, epidemiology and pathophysiology -- Acute decompensated heart failure: presentation, physical exam, and laboratory evaluation -- Acute decompensated heart failure: treatment guidelines -- Acute decompensated heart failure: treatment–specific therapies -- Acute decompensated heart failure: treatment with guideline directed medical therapy and discharge planning -- Cardiac–oncology: management of the patient with heart failure after chemotherapy -- Atrial arrhythmias and heart failure -- Ventricular arrhythmias and heart failure -- Cardiac defibrillators and heart failure -- Cardiac resynchronization therapy in heart failure -- Revascularization and heart failure -- Valve repair and replacement in congestive heart failure -- Patient selection for cardiac transplantation -- Pathophysiology of the alloimmune response and immunosuppression -- Antibody–mediated rejection -- Infections after cardiac transplantation -- Post–transplant complications: hypertension, renal dysfunction, diabetes mellitus, malignancy, arrhythmias, osteoporosis, sexual dysfunction -- Patient selection -- Acute mechanical circulatory support -- Mechanical circulatory support as a bridge to heart transplantation -- Medical management of the patient with chronic mechanical circulatory support -- The total artificial heart -- Physiology of stem cells -- Stem cell therapy in heart failure -- Origins of quality metrics -- Exercise and patients with heart failure -- Heart failure management and development of heart failure programs -- Inflammation and heart failure

Chulalinet's Book Delivery Request